Search results for:
argatroban
argatroban
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Argatroban |
SOLUTION, INTRAVENOUS |
1 mg/mL (50 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Argatroban |
SOLUTION, INTRAVENOUS |
100 mg/mL (2.5 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Mar. 4, 2024
UNC Health
UNC Health IV Compendium Guideline
Argatroban Dosing for Non-Procedural Indications in Adults and Pediatrics Guideline
Management of Heparin-Induced Thrombocytopenia Guideline
Caldwell
Emergent Anticoagulation Reversal Guideline
Johnston
Argatroban for Heparin Induced Thrombocytopenia (HIT) in Adults Policy
Anticoagulation Management Policy
Lenoir
Anticoagulation Reversal Guideline
Med Center
UNC Medical Center Formulary Restrictions
Nash
Argatroban Infusion Rate Adjustment for HIT Protocol
Pardee
Argatroban Care Reference
Rex
Management of Argatroban in Adult ICU ECMO Patients Guideline
Argatroban Protocols for Heparin Induced Thrombocytopenia (HIT) Protocol
Rockingham
Argatroban Dosing Policy
Anticoagulation Therapy Policy
Wayne
Anticoagulant Therapy Management Policy